Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Tuesday
Sep 02nd
Home arrow Farmavita.Net Journal arrow Life Science Files arrow Extended Release Multiunit Particulate System
Extended Release Multiunit Particulate System Print E-mail
Life Sciences - Life Science Article
Written by Debjit Bhowmik   
Monday, 27 July 2009

medicine_by_darren_hester.jpg

A COMPREHENSIVE REVIEW ON SUSTAIN EXTENDED RELEASE MULTIUNIT PARTICULATE ORAL DRUG DELIVERY SYSTEMS

The term ‘Sustained Release' is known to have existed in the medical and pharmaceutical literature for many decades. Sustain release has been constantly used to retard the release of therapeutic agent such that its appearance in the circulation is delayed and/or prolonged and its plasma profile is sustained in duration. The onset of its pharmacological action is often delayed and duration of therapeutic action is sustained.

The whole 31 pages article is available for download at Downloads section of Farmavita.Net

The object of sustain release of drug, in a general way is to modify the normal behaviour of drug molecule in a physiological environment. It can lead to the following.

  • Sustaining drug action at a predetermined rate by maintaining a relatively constant, effective drug level in the body with minimization of desirable side effects.
  • Localization of drug action by spatial placement of a controlled release system usually rate controlled adjacent to or in the diseased tissue of organ.
  • Targeting drug action by using carriers of chemical derivatives to deliver drug to particular target cell type.


Initially the ultimate criterion for a sustain release tablet is to achieve a blood level and the drug comparable to that of liquid product administered every 4 hrs. To this end prolong release dosage forms are designed to release the drug so as to provide a drug level within the therapeutic range for 8 to 12, with a single dose rather than a dose every 4 hrs.No prolonged drug forms have without disadvantages. Since gastrointestinal tract is not uniform. In certain individuals if drug release in higher concentration very fastly, they experience toxic or exaggerated response. If drug release was more slowly then not receive proper benefit of response was seen. This is especially true for older people whose gastrointestinal tract is less active than that of the younger. Also liberation is slow, there is danger of accumulation of the drug after several days resulting in high blood levels and a delayed exaggerated response.


Multi Unit Particulate System offers several advantages such as

  • Improve GIT absorption.
  • Minimize local irritation.
  • Offers high degree of flexibility.
  • Reduces dose dumping.
  • Reduces inter and intra subject variability.

The whole 31 pages article is available for download at Downloads section of Farmavita.Net

 

Comments
Search RSS
Only registered users can write comments!

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

Read also at Pharmaceutical Licensing Network
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!
 
< Prev   Next >
Advertisement
 

Featured Partners

 
150x150cancer.jpg
bals_150x150_anim.gif 
150-150payers.jpg  
pharmaccess14b_150x150.gif 
medaff14b_150x150.gif
bals150_150x150.gif 
150x150copd.jpg 
2014-pmr-eur-banner-150x150.gif  
2015-pmr-banner-150x150.gif 

Login to Farmavita.Net

membership is FREE

Follow us on:




Join our LinkedIn Group

BabelFish Translator




Click Flag for Translation

Who's Online

We have 118 guests online

Farmavita.Net RSS News


Reports

rbdl0002_innovations-in-inj.gif 

Events

pc_150x150.gif

Reports

rbhc0264_privatehealthcare.gif 

REPORTS

farmavita_research-store.gif